Jazz Pharmaceuticals

NeurologicalOncology

Jazz Pharmaceuticals

USA-based Jazz Pharmaceuticals (Nasdaq: JAZZ) is a specialty biopharmaceutical company.

USA-based Jazz Pharmaceuticals (Nasdaq: JAZZ) is a specialty biopharmaceutical company that identifies, develops and commercializes products to address unmet medical needs in focused therapeutic areas.

Its currently marketed products include Xyrem, Erwinaze, Prialt, Fazaclo LD and HD and Luvox RC.

Research and development efforts include programs to improve the current products in its oncology and psychiatry franchises, with four compounds in the pipeline.


Latest Articles

Latest News

Who's Who

COMPANY SPOTLIGHT

Menarini

Back to top